However, tumour tissues from Taxol or PTX/PEG2k-Fmoc-NLG(L) groups had lower percentages of T cells including Treg, CD4+ and CD8+ T cells, but higher percentage of MDSC than the group treated with PEG2k-Fmoc-NLG(L) alone. The gene discussed is CD4; the disease is neoplasm.